<DOC>
	<DOC>NCT00901199</DOC>
	<brief_summary>This is a small pilot study looking at the safety of giving combination chelation with Exjade and Desferal to 15 patients. The hypothesis is that combination chelation is safe in decreasing overall iron in patients with thalassemia.</brief_summary>
	<brief_title>Combo Chelation Trial</brief_title>
	<detailed_description />
	<mesh_term>Thalassemia</mesh_term>
	<mesh_term>Iron Overload</mesh_term>
	<mesh_term>Iron</mesh_term>
	<mesh_term>Deferasirox</mesh_term>
	<mesh_term>Deferoxamine</mesh_term>
	<criteria>Transfusion Dependent Thalassemia If iron between 515 mg/g dry liver by SQUID, subject must have a documented endocrinopathy or cardiac finding Older than 8 years Participating on another interventional clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Thalassemia</keyword>
	<keyword>Chelation</keyword>
	<keyword>Iron Overload</keyword>
	<keyword>Thalassemia patients with Iron overload</keyword>
</DOC>